Precigen, Inc., a wholly-owned subsidiary of Intrexon Corp. and a clinical stage biopharmaceutical company specializing in the development of gene and cellular therapies has opened its new manufacturing facility in Germantown, MD. The nearly 5,000 square foot GMP manufacturing facility was designed for rapid manufacturing and the ability to scale production appropriately to meet early stage clinical trial needs. The new facility adds to Precigen’s existing footprint in Germantown, which ha...